Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Nephros Inc

NEPH
Current price
1.63 USD -0.09 USD (-5.24%)
Last closed 1.62 USD
ISIN US6406714005
Sector Healthcare
Industry Medical Instruments & Supplies
Exchange NASDAQ
Capitalization 16 343 509 USD
Yield for 12 month -24.89 %
1Y
3Y
5Y
10Y
15Y
NEPH
21.11.2021 - 28.11.2021

Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey. Address: 380 Lackawanna Place, South Orange, NJ, United States, 07079

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

4.75 USD

P/E ratio

Dividend Yield

Current Year

+14 238 000 USD

Last Year

+9 975 000 USD

Current Quarter

+3 518 000 USD

Last Quarter

+3 252 000 USD

Current Year

+8 405 000 USD

Last Year

+4 731 000 USD

Current Quarter

+2 149 000 USD

Last Quarter

+1 878 000 USD

Key Figures NEPH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -1 193 000 USD
Operating Margin TTM -9.75 %
Price to Earnings
Return On Assets TTM -7.96 %
PEG Ratio
Return On Equity TTM -15.61 %
Wall Street Target Price 4.75 USD
Revenue TTM 13 770 000 USD
Book Value 0.79 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -8.30 %
Dividend Yield
Gross Profit TTM 4 731 000 USD
Earnings per share -0.090 USD
Diluted Eps TTM -0.090 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin -9.40 %

Dividend Analytics NEPH

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History NEPH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor 1:9
Payout Ratio
Last Split Date 10.07.2019

Stock Valuation NEPH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.14
Price Sales TTM 1.19
Enterprise Value EBITDA -2.16
Price Book MRQ 2.00

Financials NEPH

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators NEPH

For 52 weeks

1.36 USD 4.04 USD
50 Day MA 1.52 USD
Shares Short Prior Month 7 693
200 Day MA 1.96 USD
Short Ratio 0.040
Shares Short 7 656
Short Percent 0.010 %